Very young women (<35 years) with operable breast cancer:: features of disease at presentation

被引:285
作者
Colleoni, M
Rotmensz, N
Robertson, C
Orlando, L
Viale, G
Renne, G
Luini, A
Veronesi, P
Intra, M
Orecchia, R
Catalano, G
Galimberti, V
Nolé, F
Martinelli, G
Goldhirsch, A
机构
[1] European Inst Oncol, Dept Med, I-20141 Milan, Italy
[2] European Inst Oncol, Div Epidemiol & Biostat, I-20141 Milan, Italy
[3] European Inst Oncol, Div Pathol, I-20141 Milan, Italy
[4] Univ Milan, Sch Med, European Inst Oncol, Div Senol, Milan, Italy
[5] Univ Milan, Sch Med, European Inst Oncol, Div Radiotherapy, Milan, Italy
关键词
breast cancer; prognostic features; very young women;
D O I
10.1093/annonc/mdf039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast cancer rarely occurs in young women. Our knowledge about disease presentation, prognosis and treatment effects are largely dependent upon older series. Materials and methods: We evaluated biological features and stage at presentation for 1427 consecutive premenopausal patients aged : 50 years with first diagnosis of invasive breast cancer referred to surgery at the European Institute of Oncology from April 1997 to August 2000. A total of 185 patients (13%) were aged <35 years ('very young') and 1242 (87%) were aged 35-50 years ('less young'). The expression of estrogen receptors (ER), progesterone receptors (PgR), presence of vascular invasion (VI), grading (G), expression of Ki-67, HER2/neu overexpression, pathological stage according to TNM staging system (pTNM), pathological tumor size and number of axillary lymph node involvement were evaluated. Results: Compared with less young patients, the very young patient group had a higher percentage of tumors classified as ER negative (P < 0.001), PgR negative (P = 0.001), higher expression of Ki-67; greater than or equal to20% of cells stained; 62.2% versus 53%, (P < 0.001), vascular or lymphatic invasion (48.6% versus 37.3%, P = 0.006), and pathological grade 3 (P < 0.0001). There was no difference between the two groups for pT, pathological tumor size (pN) and number of positive lymph nodes. Conclusions: We conclude that compared with less young premenopausal patients, very young women have a greater chance of having an endocrine-unresponsive tumor, and are more likely to present with a higher grade, more extensively proliferating and vessel invading disease. Pathological tumor size, nodal status and number of positive axillary lymph-nodes have a similar distribution among the younger and the older cohorts, thus not supporting previous data indicating more advanced disease in younger patients at diagnosis of operable disease.
引用
收藏
页码:273 / 279
页数:7
相关论文
共 55 条
[1]   THE RELATION BETWEEN SURVIVAL AND AGE AT DIAGNOSIS IN BREAST-CANCER [J].
ADAMI, HO ;
MALKER, B ;
HOLMBERG, L ;
PERSSON, I ;
STONE, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (09) :559-563
[2]   Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? [J].
Aebi, S ;
Gelber, S ;
Castiglione-Gertsch, M ;
Gelber, RD ;
Collins, J ;
Thürlimann, B ;
Rudenstam, CM ;
Lindtner, J ;
Crivellari, D ;
Cortes-Funes, H ;
Simoncini, E ;
Werner, ID ;
Coates, AS ;
Goldhirsch, A .
LANCET, 2000, 355 (9218) :1869-1874
[3]  
ALBAIN KS, 1994, MONOGR NATL CANC I, V16, P35
[4]  
American Joint Committee on Cancer, 1997, AJCC CANC STAG MAN, P171
[5]   neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer [J].
Andrulis, IL ;
Bull, SB ;
Blackstein, ME ;
Sutherland, D ;
Mak, C ;
Sidlofsky, S ;
Pritzker, KPH ;
Hartwick, RW ;
Hanna, W ;
Lickley, L ;
Wilkinson, R ;
Qizilbash, A ;
Ambus, U ;
Lipa, M ;
Weizel, H ;
Katz, A ;
Baida, M ;
Mariz, S ;
Stoik, G ;
Dacamara, P ;
Strongitharm, D ;
Geddie, W ;
McCready, D .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1340-1349
[6]  
[Anonymous], 1993, Tumors of the mammary gland
[7]   C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women:: Immunohistochemical analysis and clinicopathologic correlation [J].
Bertheau, P ;
Steinberg, SM ;
Merino, MJ .
HUMAN PATHOLOGY, 1998, 29 (04) :323-329
[8]  
Chung M, 1996, CANCER, V77, P97, DOI 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO
[9]  
2-3
[10]   The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer [J].
Clahsen, PC ;
van de Velde, CJH ;
Duval, C ;
Pallud, C ;
Mandard, AM ;
Delobelle-Deroide, A ;
van den Broek, L ;
van de Vijver, MJ .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (04) :356-363